e-learning
resources
Berlin 2001
Monday 24.09.2001
Experimental and clinical models in immuno-pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
G. Folkerts, R. B. R. Muijsers, A. J. M. van Oosterhout, A. S. Koster, D. S. Postma, F. P. Nijkamp (Utrecht, Groningen, The Netherlands)
Source:
Annual Congress 2001 - Experimental and clinical models in immuno-pharmacology
Session:
Experimental and clinical models in immuno-pharmacology
Session type:
Thematic Poster Session
Number:
1792
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Folkerts, R. B. R. Muijsers, A. J. M. van Oosterhout, A. S. Koster, D. S. Postma, F. P. Nijkamp (Utrecht, Groningen, The Netherlands). Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice. Eur Respir J 2001; 16: Suppl. 31, 1792
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction
Source: Eur Respir J 2009; 34: 191-199
Year: 2009
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006
Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Nitric oxide synthase inhibitors and guinea-pigs bronchial hyperreactivity evoked by toluene
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005
Grape seed proanthocyanidin extract attenuates airway inflammation and hyperresponsiveness in a murine model of asthma: Downregulating inducible nitric oxide synthase
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response
Source: Eur Respir J 2002; 20: 609-616
Year: 2002
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003
iNOS-derived nitric oxide modulates inflammatory cell apoptosis in a model of chronic allergic pulmonary inflammation in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 760s
Year: 2006
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 432s
Year: 2006
Different effects of cNOS and iNOS-derived nitric oxide in lung mechanics in a model of chronic airway inflammation in guinea pigs: modulation by neuropeptides
Source: Eur Respir J 2005; 26: Suppl. 49, 558s
Year: 2005
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept